Table 2.
Usability testing of the app (N=175 clinicians who used each resource).
| Type of testing | n (%) | |||
| Usability testing of the BTcPa diagnostic workflow | ||||
|
|
Definitions of BTcP by Davies et al [6]/Escobar et al [16] | 146 (83.4) | ||
|
|
Davies algorithm | 141 (80.7) | ||
|
|
Other considerations of BTcP diagnosis | 46 (26.4) | ||
|
|
DN4 neuropathic scaleb | 122 (69.5) | ||
|
|
Reviewed Edmonton scaleb | 111 (63.4) | ||
| Usability testing of the app’s pain tools | ||||
|
|
Opioid rotation | 92 (52.8) | ||
|
|
Karnofsky scalec | 142 (81.3) | ||
|
|
ECOGd scale of performance statusc | 147 (84.1) | ||
|
|
Visual Numeric Scalee | 163 (93.3) | ||
|
|
Categorical Scalee | 124 (70.8) | ||
|
|
Charlson Comorbidity Index | 97 (55.4) | ||
|
|
PQRSTf questionnaire | 111 (63.7) | ||
| Usability testing of App INES·DIO | ||||
|
|
Would you include the app report with the clinical history of the patient? | |||
|
|
|
Always | 65 (37.1) | |
|
|
|
Almost always | 54 (30.9) | |
|
|
|
Occasionally | 52 (29.7) | |
|
|
|
Never | 4 (2.3) | |
|
|
Would you use App INES·DIO in a different patient profile? | |||
|
|
|
Most likely | 70 (40.0) | |
|
|
|
Likely | 52 (29.7) | |
|
|
|
Least likely | 49 (28.0) | |
|
|
|
Unlikely | 4 (2.3) | |
|
|
How many days have you used App INES·DIO on average? | |||
|
|
|
Everyday | 31 (17.7) | |
|
|
|
4-6 times per week | 38 (21.7) | |
|
|
|
2-3 times per week | 74 (42.3) | |
|
|
|
Once per week | 32 (18.3) | |
aBTcP: breakthrough cancer pain.
bTools to assess baseline pain.
cFunctional scales.
dECOG: Eastern Cooperative Oncology Group.
ePain scales.
fPQRST: (P) provocative and palliative factors; (Q) qualitative description of pain; (R) region and radiation of pain; (S) severity or intensity of pain after being scored by means of VNS and CS; (T) timing or pain changes over time.